“The Genetics of Addiction” will be the topic of a Sept 9 MDI Science Café presentation by Vivek Kumar, Ph.D., a neuroscientist at The Jackson Laboratory in Bar Harbor who researches behavior and behavioral abnormalities.
“Is There Arsenic in Your Drinking Water?” will be the subject of an MDI Science Café to be held at the MDI Biological Laboratory on Monday, July 8. The café will be held at 5 p.m. at the Maine Center for Biomedical Innovation on the campus of the MDI Biological Laboratory, 159 Old Bar Harbor Road, Salisbury Cove.
Children of all ages and their families will have an opportunity to experience science in a way that stimulates children’s interest and encourages parental involvement in science education at a Family Science Night at the MDI Biological Laboratory on Thursday, July 11, from 5 to 7 p.m.
The long history of interactions between natural science and economics will be the subject of a June 24 MDI Science Café presentation entitled “The Search for Truth in the History of Science and Economics: Some Surprising Connections.”
The MDI Biological Laboratory has received an award of nearly $18 million from the National Institute of General Medical Sciences (NIGMS), an Institute of the National Institutes of Health (NIH), for the renewal of a grant to strengthen biomedical research and research training in Maine.
The role of next-generation therapies in cancer treatment will be the subject of a March 11 MDI Science Café entitled “The Frontiers of Cancer Research” by cancer biologist/immunologist Muneer G. Hasham, Ph.D., of The Jackson Laboratory.
Fourth graders from elementary schools on Mount Desert Island and in Trenton visited the MDI Biological Laboratory in Bar Harbor during the week of Nov. 26 for an introduction to biology.
The MDI Biological Laboratory welcomed state and national officials to a Nov. 2 workshop for scientist-mentors involved in an innovative new data-to-action citizen science program led by the laboratory.
Pharmaceutical developers are under increasing pressure to deliver high-value products that are affordable to patients and society. But the costs of bringing new drugs to market are significant. What’s involved in bringing a new drug to market and what is considered when valuing these new therapies? Former pharmaceutical company executive Josephine A. Sollano, DrPH, will discuss this timely topic at a Science Café entitled “Demystifying the Valuation of Pharmaceutical Innovations” to be…